Cargando…

The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons

PURPOSE: Subretinal injection (SRI) in mice is widely used in retinal research, yet the learning curve (LC) of this surgically challenging technique is unknown. METHODS: To evaluate the LC for SRI in a murine model, we analyzed training data from three clinically trained ophthalmic surgeons from 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Peirong, Narendran, Siddharth, Pereira, Felipe, Fukuda, Shinichi, Nagasaka, Yosuke, Apicella, Ivana, Yerramothu, Praveen, Marion, Kenneth M., Cai, Xiaoyu, Sadda, Srinivas R., Gelfand, Bradley D., Ambati, Jayakrishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934552/
https://www.ncbi.nlm.nih.gov/pubmed/35275207
http://dx.doi.org/10.1167/tvst.11.3.13
_version_ 1784671872376373248
author Huang, Peirong
Narendran, Siddharth
Pereira, Felipe
Fukuda, Shinichi
Nagasaka, Yosuke
Apicella, Ivana
Yerramothu, Praveen
Marion, Kenneth M.
Cai, Xiaoyu
Sadda, Srinivas R.
Gelfand, Bradley D.
Ambati, Jayakrishna
author_facet Huang, Peirong
Narendran, Siddharth
Pereira, Felipe
Fukuda, Shinichi
Nagasaka, Yosuke
Apicella, Ivana
Yerramothu, Praveen
Marion, Kenneth M.
Cai, Xiaoyu
Sadda, Srinivas R.
Gelfand, Bradley D.
Ambati, Jayakrishna
author_sort Huang, Peirong
collection PubMed
description PURPOSE: Subretinal injection (SRI) in mice is widely used in retinal research, yet the learning curve (LC) of this surgically challenging technique is unknown. METHODS: To evaluate the LC for SRI in a murine model, we analyzed training data from three clinically trained ophthalmic surgeons from 2018 to 2020. Successful SRI was defined as either the absence of retinal pigment epithelium (RPE) degeneration after phosphate buffered saline injection or the presence of RPE degeneration after Alu RNA injection. Multivariable survival-time regression models were used to evaluate the association between surgeon experience and success rate, with adjustment for injection agents, and to calculate an approximate case number to achieve a 95% success rate. Cumulative sum (CUSUM) analyses were performed and plotted individually to monitor each surgeon's simultaneous performance. RESULTS: Despite prior microsurgery experience, the combined average success rate of the first 50 cases in mice was only 27%. The predicted SRI success rate did not reach a plateau above 95% until approximately 364 prior cases. Using the 364 training cases as a cutoff point, the predicted probability of success for cases 1 to 364 was 65.38%, and for cases 365 to 455 it was 99.32% (P < 0.0001). CUSUM analysis showed an initial upward slope and then remained within the decision intervals with an acceptable success rate set at 95% in the late stage. CONCLUSIONS: This study demonstrates the complexity and substantial LC for successful SRI in mice with high confidence. A systematic training system could improve the reliability and reproducibility of SRI-related experiments and improve the interpretation of experimental results using this technique. TRANSLATIONAL RELEVANCE: Our prediction model and monitor system allow objective quantification of technical proficiency in the field of subretinal drug delivery and gene therapy for the first time, to the best of our knowledge.
format Online
Article
Text
id pubmed-8934552
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-89345522022-03-21 The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons Huang, Peirong Narendran, Siddharth Pereira, Felipe Fukuda, Shinichi Nagasaka, Yosuke Apicella, Ivana Yerramothu, Praveen Marion, Kenneth M. Cai, Xiaoyu Sadda, Srinivas R. Gelfand, Bradley D. Ambati, Jayakrishna Transl Vis Sci Technol Article PURPOSE: Subretinal injection (SRI) in mice is widely used in retinal research, yet the learning curve (LC) of this surgically challenging technique is unknown. METHODS: To evaluate the LC for SRI in a murine model, we analyzed training data from three clinically trained ophthalmic surgeons from 2018 to 2020. Successful SRI was defined as either the absence of retinal pigment epithelium (RPE) degeneration after phosphate buffered saline injection or the presence of RPE degeneration after Alu RNA injection. Multivariable survival-time regression models were used to evaluate the association between surgeon experience and success rate, with adjustment for injection agents, and to calculate an approximate case number to achieve a 95% success rate. Cumulative sum (CUSUM) analyses were performed and plotted individually to monitor each surgeon's simultaneous performance. RESULTS: Despite prior microsurgery experience, the combined average success rate of the first 50 cases in mice was only 27%. The predicted SRI success rate did not reach a plateau above 95% until approximately 364 prior cases. Using the 364 training cases as a cutoff point, the predicted probability of success for cases 1 to 364 was 65.38%, and for cases 365 to 455 it was 99.32% (P < 0.0001). CUSUM analysis showed an initial upward slope and then remained within the decision intervals with an acceptable success rate set at 95% in the late stage. CONCLUSIONS: This study demonstrates the complexity and substantial LC for successful SRI in mice with high confidence. A systematic training system could improve the reliability and reproducibility of SRI-related experiments and improve the interpretation of experimental results using this technique. TRANSLATIONAL RELEVANCE: Our prediction model and monitor system allow objective quantification of technical proficiency in the field of subretinal drug delivery and gene therapy for the first time, to the best of our knowledge. The Association for Research in Vision and Ophthalmology 2022-03-11 /pmc/articles/PMC8934552/ /pubmed/35275207 http://dx.doi.org/10.1167/tvst.11.3.13 Text en Copyright 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Article
Huang, Peirong
Narendran, Siddharth
Pereira, Felipe
Fukuda, Shinichi
Nagasaka, Yosuke
Apicella, Ivana
Yerramothu, Praveen
Marion, Kenneth M.
Cai, Xiaoyu
Sadda, Srinivas R.
Gelfand, Bradley D.
Ambati, Jayakrishna
The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons
title The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons
title_full The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons
title_fullStr The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons
title_full_unstemmed The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons
title_short The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic Surgeons
title_sort learning curve of murine subretinal injection among clinically trained ophthalmic surgeons
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934552/
https://www.ncbi.nlm.nih.gov/pubmed/35275207
http://dx.doi.org/10.1167/tvst.11.3.13
work_keys_str_mv AT huangpeirong thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT narendransiddharth thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT pereirafelipe thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT fukudashinichi thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT nagasakayosuke thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT apicellaivana thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT yerramothupraveen thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT marionkennethm thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT caixiaoyu thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT saddasrinivasr thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT gelfandbradleyd thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT ambatijayakrishna thelearningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT huangpeirong learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT narendransiddharth learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT pereirafelipe learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT fukudashinichi learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT nagasakayosuke learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT apicellaivana learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT yerramothupraveen learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT marionkennethm learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT caixiaoyu learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT saddasrinivasr learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT gelfandbradleyd learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons
AT ambatijayakrishna learningcurveofmurinesubretinalinjectionamongclinicallytrainedophthalmicsurgeons